ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Charles River Acquires Retrogenix
April 06, 2021Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million. -
Retrogenix and Resonant Therapeutics announce strategic alliance to identify targets of anti-tumour antibodies
December 16, 2019UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced that they have entered into a non-exclusive strategic partnership to ...
Pharma Sources Insight January 2025
